Jonsson A B, Perner A
Department of Intensive Care, Rigshospitalet, Copenhagen, Denmark.
Acta Anaesthesiol Scand. 2017 May;61(5):532-538. doi: 10.1111/aas.12887.
In recent years, large trials have increased the level of evidence for intravenous (IV) fluid therapy, at least in the intensive care setting. It is less clear whether this change in the evidence base has been associated with changes in IV fluid use in different hospital departments.
We obtained details from the regional pharmacy regarding IV fluids issued to hospital departments in the Danish Capitol Region from January 2012 to May 2015. We used paired Wilcoxon's signed-rank test to analyse changes in the issuing in different departments.
Total regional issuing of IV fluids showed increase in crystalloid solutions (9%; P = 0.001) and decrease in colloid solutions (59%; P = 0.005). Subtype analysis showed increased issuing of buffered crystalloids (36%; P = 0.001), human albumin (30%; P < 0.0001) and decreased issuing in synthetic colloid solutions (82%; P < 0.0001) from Q1 2012 to Q2 2015. At the departmental level, the issuing of synthetic colloid solutions decreased markedly to all settings. The issuing of buffered crystalloids increased to orthopaedic (226%; P = 0.03) and to general surgery departments (686%; P = 0.002). Albumin solutions were increasingly issued to anaesthesia departments (63%; P = 0.005) and was rarely issued to general surgery and orthopaedic departments.
The issuing of IV fluid solutions to hospital departments has changed markedly over the last years to less colloid, in particular the synthetic solutions, and relatively more issuing of crystalloids, in particular the buffered solutions.
近年来,大型试验提高了静脉输液治疗的证据水平,至少在重症监护环境中如此。目前尚不清楚证据基础的这种变化是否与不同医院科室静脉输液使用的变化相关。
我们从地区药房获取了2012年1月至2015年5月期间发放给丹麦首都地区医院科室的静脉输液的详细信息。我们使用配对威尔科克森符号秩检验来分析不同科室发放情况的变化。
地区静脉输液的总发放量显示晶体溶液增加(9%;P = 0.001),胶体溶液减少(59%;P = 0.005)。亚型分析显示,从2012年第一季度到2015年第二季度,缓冲晶体溶液发放量增加(36%;P = 0.001),人白蛋白发放量增加(30%;P < 0.0001),合成胶体溶液发放量减少(82%;P < 0.0001)。在科室层面,合成胶体溶液在所有科室的发放量均显著下降。缓冲晶体溶液在骨科(226%;P = 0.03)和普通外科科室(686%;P = 0.002)的发放量增加。白蛋白溶液在麻醉科的发放量越来越多(63%;P = 0.005),而在普通外科和骨科科室很少发放。
在过去几年中,医院科室静脉输液溶液的发放情况发生了显著变化,胶体溶液减少,尤其是合成溶液,晶体溶液发放相对增多,尤其是缓冲溶液。